High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Hims and Hers has 2.6 million subscribers, a battered stock price, and a CEO buying shares instead of signaling an exit. That combination puts a very specific list of giants on alert, and only one of them is a clean fit.
Guardant Health (NASDAQ:GH) reported second-quarter 2026 revenue of $335 million, up 44% from a year earlier, as growth accelerated across its oncology, biopharma and data, and screening businesses. The company also raised its full-year revenue outlook, citing demand for its Guardant360 and Shield o
The Centers for Medicare & Medicaid Services (CMS) announced Tuesday it will end the Medicare Part D Premium Stabilization Demonstration after the 2026 plan year, ending a federal subsidy program that has helped keep prescription drug premiums lower and could...
Humana (NYSE:HUM) said its 2026 performance is tracking in line with expectations, with management emphasizing planned Medicare Advantage margin expansion in 2027, progress in its Stars program and continued operating-cost reductions as key components of its path toward a sustainable pretax margin o
ENI (NYSE:E) reported sharply higher second-quarter and first-half results, citing upstream production growth, favorable market conditions and stronger contributions from its gas, low-carbon and refining-related businesses. Chief Executive Officer Claudio Descalzi said second-quarter pro forma EBIT
Program that held down premiums won’t be renewed for 2027, resulting in higher costs for some seniors.
Medicare beneficiaries may face higher premiums next year for their Part D drug plans, as the federal government plans to end subsidies that helped mitigate price increases in the program. The Trump administration will not continue the subsidies beyond 2026, The Wall Street Journal reported. About 25 million Medicare recipients are enrolled in a stand-alone Part D plan for their drug coverage.
Humana reports earnings Wednesday after its stock surged this year on improving confidence in Medicare Advantage insurers. Investors will be watching medical costs and the company’s outlook.
UnitedHealth Group (UNH) just delivered the quarter battered shareholders have been waiting for. The health care company blew past Wall Street's profit prediction, increased its most widely monitored cost index, and boosted its full-year earnings outlook. The results seemed to vindicate investors ...
UnitedHealth Group (UNH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
UnitedHealth Group (UNH) beat Wall Street's numbers on July 16, 2026, but its chief financial officer spent the earnings call making sure nobody mistook that result for a solved cost problem. The company beat earnings estimates by roughly 30%, and management raised full-year guidance well past ...
(Bloomberg) -- Circle Internet Group Inc. shares have lost more than three-quarters of their value from the highs seen just after their initial public offering last year and as more stablecoins come to market, one analyst is warning it could get worse.Most Read from BloombergThailand Scraps Plan to End Visa-Free Entry for Indian TouristsGoogle Gemini Launch Delayed as Tech Falls Short of Internal GoalsBeckham’s IM8 Gets $1 Billion From General Catalyst for GrowthCIA Says AI Drones Give Russian T
CEO Hemsley reports 55% operating earnings growth and raises full-year guidance.
UnitedHealth Group Incorporated will release earnings for its second quarter before the opening bell on Thursday, July 16. Analysts expect the company to report quarterly earnings of $4.85 per share, up from $4.08 per share in the year-ago period. The...
UnitedHealth shares jumped to their highest level in more than a year Thursday after the health care and insurance giant reported better-than-expected quarterly results.
UnitedHealth Group Inc (UNH) reports a significant rise in adjusted EPS and operating earnings, while navigating cost pressures and strategic investments in AI.
Q2 earnings are off to a strong start. Tech, Energy, Materials, Finance and Aerospace ETFs could shine as profit growth broadens across sectors.
UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares climbed about 5% in post-market trading after the healthcare company reported second quarter results that beat Wall Street expectations and raised its full-year adjusted earnings outlook. For the quarter ended June 30, UnitedHealth reported...
UnitedHealth Group (NYSE:UNH) reported sharply higher second-quarter 2026 earnings and raised its full-year outlook, citing improved performance in Medicare Advantage and Optum Health, while cautioning that commercial medical cost trends remain elevated and are delaying margin recovery in that busin
While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
UnitedHealth (UNH) raised its full-year earnings outlook on Thursday as the health insurance giant r
By Amina Niasse NEW YORK, July 16 (Reuters) - UnitedHealth Group raised on Thursday its 2026 profit forecast as the company tightened spending on medical costs and improved operating income in its
Today Earnings (a.m): UnitedHealth, GE Aerospace, U.S. Bancorp, Citizens Financial, Abbott Laboratories, State Street, Taiwan Semiconductor Manufacturing Earnings (p.m.): Netflix, Intuitive Surgical Economic data: Weekly jobless claims, Philadelphia Fed business-outlook survey, retail sales, pending home sales index, business inventories Fed speakers: Fed Vice Chair Philip Jefferson is expected to speak, as is Dallas Fed President Lorie Logan.
UnitedHealth Group’s stock fell hard in 2025. When the healthcare insurer reports second-quarter results Thursday, the company’s 2026 bounceback has investors eager for confirmation that medical spending trends are in hand. UnitedHealth has notched a series of wins heading into earnings season.
Dell, Sandisk and Micron led an AI sell-off, masked by megacaps such as Apple. SpaceX undercut its IPO price. Taiwan Semi, GE Aerospace earnings are due.
Elevance Health topped Q2 earnings estimates Wednesday, despite falling medical membership, but profit was boosted by one-time "below-the-line" factors and the full-year outlook was underwhelming. ELV stock tumbled, making it among the S&P 500's early laggards. Molina Healthcare, another S&P 500 managed care stock, joined Elevance among the biggest laggards performers in pre-market trading.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
